174 related articles for article (PubMed ID: 1286766)
1. Technical requirements of veterinary vaccines for registration--FEDESA's point of view.
Watson J
Dev Biol Stand; 1992; 79():51-63. PubMed ID: 1286766
[No Abstract] [Full Text] [Related]
2. The FEDESA's point of view.
Folkers C
Dev Biol Stand; 1992; 79():27-30. PubMed ID: 1286760
[No Abstract] [Full Text] [Related]
3. Regulatory requirements for vaccine authorisation.
Jones PG; Cowan G; Gravendyck M; Nagata T; Robinson S; Waits M
Rev Sci Tech; 2007 Aug; 26(2):379-93. PubMed ID: 17892159
[TBL] [Abstract][Full Text] [Related]
4. Regulations for vaccines against emerging infections and agrobioterrorism in the United States of America.
Elsken LA; Carr MY; Frana TS; Brake DA; Garland T; Smith K; Foley PL
Rev Sci Tech; 2007 Aug; 26(2):429-41. PubMed ID: 17892163
[TBL] [Abstract][Full Text] [Related]
5. License requirements and agents licensed.
Price RJ; Espeseth DA
J Am Vet Med Assoc; 1972 Feb; 160(4):507-9. PubMed ID: 5063983
[No Abstract] [Full Text] [Related]
6. Presentation of the directive 81/852/EEC (92/18) safety testing.
Vannier P
Dev Biol Stand; 1992; 79():47-50. PubMed ID: 1286765
[TBL] [Abstract][Full Text] [Related]
7. [Registering, licensing and investigating vaccines in animal disease control (author's transl)].
Lensing HH; van Leeuwen JM; Oei HL
Tijdschr Diergeneeskd; 1979 Jun; 104(12):517-20. PubMed ID: 462459
[TBL] [Abstract][Full Text] [Related]
8. The role of the European Pharmacopoeia.
Artiges A
Dev Biol Stand; 1992; 79():87-93. PubMed ID: 1286769
[No Abstract] [Full Text] [Related]
9. Control of product batches (before and after registration). The Belgian approach.
Pensaert M
Dev Biol Stand; 1992; 79():183-6. PubMed ID: 1286756
[TBL] [Abstract][Full Text] [Related]
10. Harmonization of testing requirements for veterinary vaccines.
Bellinzoni R
Dev Biol (Basel); 2004; 119():381-2. PubMed ID: 15742650
[No Abstract] [Full Text] [Related]
11. FEDESA's point of view: quality, application to IVMPs (immunological veterinary medicinal products).
Soulebot JP
Dev Biol Stand; 1992; 79():201-11. PubMed ID: 1286759
[No Abstract] [Full Text] [Related]
12. National considerations in the Nordic countries regarding vaccine licensing.
Gunnarsson E; Lund A; Høy T; Larsson B; Sihvonen L
Acta Vet Scand Suppl; 1996; 90():85-7. PubMed ID: 8996893
[No Abstract] [Full Text] [Related]
13. Regulatory considerations for emergency use of non-USDA licensed vaccines in the United States.
Hill RE; Foley PL; Carr MY; Elsken LA; Gatewood DM; Ludemann LR; Wilbur LA
Dev Biol (Basel); 2003; 114():31-52. PubMed ID: 14677675
[TBL] [Abstract][Full Text] [Related]
14. Regulatory considerations for marker vaccines and diagnostic tests in the U.S.
Foley PL; Hill RE
Biologicals; 2005 Dec; 33(4):253-6. PubMed ID: 16257538
[TBL] [Abstract][Full Text] [Related]
15. Some remarks on the efficacy of vaccines for veterinary use.
Lensing HH
Dev Biol Stand; 1992; 79():43-5. PubMed ID: 1286764
[No Abstract] [Full Text] [Related]
16. Regulation of immunologicals in the European union: current and emerging issues.
Kriz NG;
Biologicals; 2005 Dec; 33(4):247-52. PubMed ID: 16289997
[No Abstract] [Full Text] [Related]
17. [Animal experimentation in the discovery and production of veterinary vaccines].
Audonnet JCh; Lechenet J; Verschuere B
Rev Sci Tech; 2007 Aug; 26(2):443-9. PubMed ID: 17892164
[TBL] [Abstract][Full Text] [Related]
18. Licensing of veterinary vaccines.
Fries HH
Acta Vet Scand Suppl; 1996; 90():83-4. PubMed ID: 8996892
[No Abstract] [Full Text] [Related]
19. European regulations relevant to the marketing and use of fish vaccines.
Lee A
Dev Biol Stand; 1997; 90():341-6. PubMed ID: 9270862
[TBL] [Abstract][Full Text] [Related]
20. [The Spanish translation of the Manual of Diagnostic Tests and Vaccines for Terrestrial Animals: current and future solutions].
Díez FG; León FC
Rev Sci Tech; 2004 Dec; 23(3):1023-31. PubMed ID: 15861898
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
